Image For Activity Cover
Insulin Management and Strategies
Module Description
This module aims to provide health care professionals with a comprehensive understanding of insulin management in diabetes, focusing on current recommendations, insulin products, and strategies for personalized glycemic control. Participants will explore the initiation of insulin therapy, differentiate between insulin products, and develop skills in modifying insulin regimens to meet individualized glycemic goals. 
Learning Objectives
At the end of this module, participants will be able to:
  1. Recall current recommendations for insulin use in diabetes and identify appropriate indications for initiating insulin. 
  2. Differentiate insulin types by their action profiles and clinical characteristics.
  3. Contrast the various types of insulin delivery programs to optimally select one that is appropriate for each patient.  
  4. Apply recommendations for modification of insulin therapies to adjust treatment to meet individualized glycemic goals.
  5. Apply methods of initiation and titration of insulin based on patient centered strategies including insulin-to-carb ratio, insulin sensitivity factor, and carb counting.
Module Faculty

Ricard S. Beaser, MD 

Richard S. Beaser, M.D., is currently the Senior Strategic Advisor for Educational Services at the Joslin Diabetes Center and a Corresponding Member of the Faculty of Medicine, Harvard Medical School. He recently retired from patient care in the Adult Diabetes Section of the Joslin Clinic (Joslin Diabetes Center) where he had also been the Medical Director, Continuing Medical Education and Senior Strategic Advisor, Education Programs.  He was also an Associate Professor of Medicine at Harvard Medical School, Boston, MA.

Dr. Beaser is a native of Massachusetts, graduated from Trinity College, Hartford in 1973, and from Boston University School of Medicine with an MD degree in 1977.  He did his residency at the University of Massachusetts Medical Center in Worcester from 1977-1980.  He was a fellow in endocrinology at the Joslin Diabetes Center, Boston, MA 1980-81, and in Endocrinology at the Lahey Clinic Medical Center, Burlington, MA 1981-82. 

Dr. Beaser joined the staff of the Joslin Diabetes Center in 1982.  He has held numerous past positions at Joslin, including Section Chief of the Adult Diabetology Practice, Medical Director of the Diabetes Treatment Unit, and Coordinator of the Patient Education Section.  He has been a clinical research investigator, including the landmark Diabetes Control and Complications Trial.  Dr. Beaser has authored multiple editions of 4 books: Joslin Diabetes Manual (1989), Outsmarting Diabetes (1994), The Joslin Guide to Diabetes (1995, 2005), and Joslin’s Diabetes Deskbook: A Guide for Primary Care Providers (2001, 2003, 2007, 2010, 2014).  He is a well-known national lecturer/faculty on clinical diabetes and its comorbidities.  He also had been in an active clinical practice of adult diabetes at both the Joslin Diabetes Center in Boston and in Needham, Massachusetts until his retirement from clinical care in June, 2023. 

Dr. Beaser founded the Professional Education Department at Joslin Diabetes Center in the early 1990’s, serving as Medical Director of the Continuing Medical Education Department, leading the many educational outreach efforts of this world-recognized Diabetes Center.  He was responsible for overseeing project and activity development.  In his role as Senior Strategic Advisor, Education Programs at the Joslin Diabetes Center, which he continues currently, he leverages his years of Professional Education experience in assisting groups within Joslin who are developing professional education programs, materials, and interventions both domestically and internationally.  In these roles, he continues to lecture, and develop and/or oversee educational content production for Joslin, and also consult on the academic development/production of various external educational projects which target physicians, other medical professionals, and patients.

A picture containing person, clothing, person, posingDescription automatically generated

 

Nuha El Sayed, MD, MMSc 

Dr. El Sayed is the Vice President of Healthcare Improvement, American Diabetes Association. 

She oversees the development of the ADA's Standards of Medical Care and consensus statements, serves as chair of the Professional Practice Committee, and heads the professional education and accreditation. She also leads the quality improvement and international programs for the American Diabetes Association. 
 
Dr. El Sayed is an endocrinologist and faculty at Harvard Medical School. Her clinical expertise includes general diabetes, diabetes prevention, lifestyle medicine, and diabetes technology. She has over a decade of experience in combined diabetes and quality improvement and training programs nationally and internationally. Her programs include training healthcare workforces, professionals, trainees, and students across the US and the globe to support the improvement of diabetes care. 

A picture containing person, smiling, posingDescription automatically generated


Alissa R. Segal, PharmD, RPh, CDCES, CDTC, FCCP


Dr. Segal is a Professor of Pharmacy Practice, clinical pharmacist and certified diabetes care and education specialist with the Massachusetts College of Pharmacy & Health Sciences, Boston, MA.

After completing post-doctorate residencies at the Medical Center at Princeton and the Medical University of South Carolina, Dr. Segal spent several years of teaching at the University of New Mexico, where she also cared for patients and completed scholarly work in family practice, with a focus on diabetes care. In 2007, Dr. Segal joined MCPHS and established clinical pharmacy services at the Joslin Diabetes Center. Her research focus on the care of adults with diabetes has led to numerous publications on topics, including: diabetes in older adults and concentrated insulin, pharmacotherapy guidelines for patients with type 2 diabetes, and book chapters in the Joslin Deskbook, Endocrine and Metabolic Medical Emergencies, and Geriatric Diabetes. Dr. Segal has also developed education modules for the Joslin Diabetes Center, International Diabetes Federation and the American Diabetes Association. She also serves on the ADA’s Primary Care Advisory Group and Professional Practice Committees, and is a fellow of the American College of Clinical Pharmacy.

 


Rozalina McCoy, MD, MS 

Dr. McCoy is Associate Professor of Medicine at Mayo Clinic in Rochester, MN, where she is a practicing primary care physician, endocrinologist, and medical director of the Mayo Clinic Ambulance Community Paramedic Program. Dr. McCoy is a NIH-, PCORI-, and AHRQ-funded health services researcher whose work leverages real-world evidence to improve the quality, equity, and accessibility of diabetes care. 

Dr. McCoy is an active member of the American Diabetes Association, where she currently serves as Chair-Elect of the Diabetes in Primary Care Interest Group and is a member of the Primary Care Advisory Group. Dr. McCoy received her undergraduate degree at Harvard, medical degree at Johns Hopkins, completed her medical training in internal medicine and endocrinology at Mayo Clinic, and has been on faculty at Mayo Clinic since 2015.

 


Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP

Dr. Neumiller is vice-chair and the Allen I. White Distinguished Associate Professor in the Department of Pharmacotherapy at Washington State University in Spokane. He is a contributing author for the ADA books Medications for the Treatment of Diabetes and Practical Insulin. A past editor-in-chief of the ADA journal Diabetes Spectrum, he currently serves on the editorial board of BMJ Open Diabetes Research & Care. 

From 2018 to 2019, Dr. Neumiller was chairman of the ADA’s Professional Practice Committee, whose primary responsibility was revising the ADA’s Standards of Medical Care in Diabetes each year. His research interests involve the management of diabetes and chronic kidney disease. In 2016, he was awarded the Albert B. Prescott Pharmacy Leadership Award, and in 2021 he was named the Association of Diabetes Care & Education Specialists Diabetes Educator of the Year. 

 

Discussion Board

This course will feature an Online Learning Collaborative that will utilize the discussion board. 

Participating in the discussion forum offers a valuable platform for sharing insights, posing questions, and networking with fellow professionals in the field of diabetes care. Your contributions will help to shape upcoming discussions led by renowned subject matter experts. Take advantage of this opportunity to engage, learn from others' experiences, and foster a collaborative learning environment.  

The American Diabetes Association (ADA) hosts an online learning collaborative (OLC) to provide a platform for individuals interested in diabetes education and related topics to exchange information, experiences, and opinions. Please be aware that the comments and content posted by users within the OLC represent the views and opinions of those individual users and do not necessarily reflect the official stance or opinion of the American Diabetes Association.

The ADA values diverse perspectives and encourages open and respectful dialogue among OLC members. However, the ADA does not endorse or take responsibility for the accuracy, completeness, or appropriateness of the content shared within the OLC.

By participating in the OLC, you acknowledge and agree that:

1. The content posted by other users is their own, and the ADA does not assume any liability for the content's accuracy, legality, or quality.

2. You are responsible for evaluating the information and advice provided by other OLC members.

3. The ADA reserves the right to moderate and remove content that violates community guidelines or is deemed inappropriate, offensive, or harmful to others.

Participation in the OLC is subject to adherence to the ADA's terms of use and community guidelines. The ADA encourages respectful and constructive discussions that benefit all members of the diabetes community.

Your engagement within the OLC signifies your acceptance of this disclaimer and your commitment to maintaining a supportive and informative environment for all participants.

IMPORTANT: Managing email notifications

After you post to the discussion board, you will automatically be enrolled in email alerts.

To avoid receiving an email every time someone posts to the discussion board, click the Following link.

Course Support
If you have questions about this course, please email professionaleducation@diabetes.org .
Summary
Availability: On-Demand
Cost: FREE
Credit Offered:
1.5 CME Credits
1.5 ABIM-MOC Points
1.5 ACPE Credits
1.5 ANCC Credits
1.5 AAPA Credits
1.5 CDR Credits
1.5 COP Credits
American Diabetes Association 2451 Crystal Drive, Suite 900, Arlington, VA 22202 1-800-DIABETES
Follow us on
Copyright All rights reserved.
Android App Download IOS App Download Powered By